Are all IV thrombolysis exclusion criteria necessary? Being SMART about evidence-based medicine

Neurology. 2011 May 24;76(21):1780-1. doi: 10.1212/WNL.0b013e31821ccd60. Epub 2011 Apr 13.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Clinical Trials as Topic
  • Contraindications
  • Evidence-Based Medicine*
  • Guidelines as Topic*
  • Humans
  • Injections, Intravenous
  • Patient Selection
  • Stroke / drug therapy*
  • Thrombolytic Therapy*
  • Time Factors
  • Tissue Plasminogen Activator / administration & dosage
  • Tissue Plasminogen Activator / therapeutic use

Substances

  • Tissue Plasminogen Activator